Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC1A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GRIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF502 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1211L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ROBO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZAP70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSC22D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928673 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIMAP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on